News
Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...
A newly developed radiolabeled antibody that targets the cancer antigen IL13Rα2 has been found to be highly specific, binding ...
Many patent applicants currently face difficulty in obtaining antibody claims because of written description and enablement ...
Discover comprehensive insights into approved therapeutics and research developments targeting Prostate-Specific Membrane Antigen (PSMA). This product provides detailed competitor analysis, R&D stages ...
Antibody Solutions, a leading provider of fit-for-purpose antibody discovery services, announced today that for the first ...
such as antigens or immunogens. That binding process depends on many factors. “One often overlooked parameter is the exact binding site of your antibody on the protein of interest, also known as ...
“Now, we can capture the entire antigen-specific B-cell repertoire ... and BLI for the validation of antibody binding to the target(s) of interest. “We’re confident that our antibody ...
Debiopharm, Oncodesign Services announce license agreement for use of AbYlink technology for pre-clinical services: Martigny, Switzerland Saturday, April 26, 2025, 17:00 Hrs [IST] ...
15d
Clinical Trials Arena on MSNSeismic Therapeutic doses healthy subject cohort in Phase I trial of S-4321Seismic Therapeutic has dosed the first healthy participant cohort in the randomised Phase I trial of bifunctional antibody S-4321.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results